Shanghai Constream Biotech was established in 2023

About Us

ABOUT CONSTREAM BIOTECH

Constream Biotech

Constreambio is a newly established biotechnology company focusing on antibody discovery and early research one-stop services, aiming to help the pharmaceutical industry reduce costs and increase efficiency. Established in July 2023, the company brings together experts from renowned universities such as Shanghai Jiao Tong University and Fudan University, boasting over 15 years of experience in biopharmaceutical development. In 2024, it completed tens of millions of angel round financing. Constreambio has established six major technology platforms, providing full-process services from antibody design to large-scale production. The company's founding team possesses professional expertise in antibody humanization, modification, and protein antibody preparation. It plans to establish a billion-level fully human Fab synthetic library by 2026, providing high-affinity, high-specificity candidate antibodies for the pharmaceutical and diagnostic industries. The goal is to fill the gap in domestic substitution, promote independent innovation and industrial upgrading in China's pharmaceutical industry, achieve domestic production, improve product accessibility, and benefit patients.

Corporate Culture


The stream flows long, steady progress

Corporate Values

Innovation leads, pursuit of excellence, courage to take responsibility, win-win cooperation

Corporate Vision

To become a world-renowned antibody molecule discovery service platform

Company Slogan

Focus on antibody molecule discovery and early research

Service Concept

Understand customers, serve customers, achieve customers

Honors and Qualifications


The pursuit of excellence is the concept our company upholds. We will, according to customer needs and social development, continuously integrate advanced technologies such as intelligence, data, modularity, high automation, and environmental protection into our products to provide customers with equipment, improve the level of production equipment, and make progress and develop together.

Class A Qualification for Information System Security Integration
Class A Qualification for Information System Security Integration
Class A Qualification for Information System Security Integration
Class A Qualification for Information System Security Integration
Class A Qualification for Information System Security Integration
Class A Qualification for Information System Security Integration

Development History


Company established

Completed the signing of the first project contract

Completed tens of millions of yuan in angel round financing

600-square-meter Qingpu laboratory opens

A hundred billion-level fully human Fab phage library has been launched

Reached a cooperation with a leading innovative pharmaceutical company

2023-07

2023-08

2024-02

2024-05

2024-08

2025-02


Join us


Senior Research Scientist or Manager, Antibody Discovery

Full-time

Job Location:

Number of Recruitments:

1

Salary:

5,000-7,000

Publish Time:

2025-04-02

Reagent Kit Development Researcher (1-2 positions)

Full-time

Job Location:

Number of Recruitments:

1

Salary:

60,000-120,000

Publish Time:

2025-04-02

Antibody Discovery Technology Service BD Manager

Full-time

Job Location:

Number of Recruitments:

1

Salary:

15,000-30,000

Publish Time:

2025-04-02

Senior phage library screening engineer

Full-time

Job Location:

Number of Recruitments:

1

Salary:

12,000-24,000

Publish Time:

2025-04-02

Vice President of Sales

Full-time

Job Location:

Number of Recruitments:

1

Salary:

18,000-36,000

Publish Time:

2025-04-02

< 12 >